As shown in Fig. 3, we noted that CD8+ T cell from RCC patient TC on day 0 exhibited a higher apoptotic rate when compared with T cells from the two normal donors (p < 0.003) and this data was exacerbated after 35 days of MLTC (p < 0.0001). The gene discussed is CD8A; the disease is renal cell carcinoma.